| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 72,634 | 80,687 | 48,183 | | Cost of Revenue | 49,036 | 52,462 | 32,487 | | | Gross Profit | 23,598 | 28,225 | 15,696 | | | Operating Expenses | | Research Development | 1,942 | 1,832 | 1,078 | | Selling General and Administrative | 21,712 | 19,032 | 12,621 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (56) | 7,361 | 1,997 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,661 | 1,189 | 201 | | Earnings Before Interest And Taxes | 1,605 | 8,550 | 2,198 | | Interest Expense | 167 | 1,390 | 1,044 | | Income Before Tax | 1,438 | 7,160 | 1,154 | | Income Tax Expense | 927 | 2,750 | 225 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 511 | 4,410 | 929 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 511 | 4,410 | 929 | | Preferred Stock And Other Adjustments |
-
| (1,000) | (489) | | | Net Income Applicable To Common Shares | $511 | $3,410 | $440 |
|
0.29% Nasdaq 
0.18 (4.93%) 
Income Statement
